#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Partial lipodystrophy Hairy cell leukaemia Cutaneous T-cell lymphoma recurrent Rhabdomyosarcoma Pustular psoriasis Sarcoidosis Complex regional pain syndrome Pleural mesothelioma malignant B-cell small lymphocytic lymphoma recurrent Fontan procedure Transitional cell cancer of the renal pelvis and ureter Anal squamous cell carcinoma Warm autoimmune haemolytic anaemia Follicular lymphoma stage I Glioma More trials…

    Learn about Rare Diseases

    Mast cell activation syndrome SAPHO syndrome Glycogen storage disease type V – Trials in Disease Breast angiosarcoma – Treatment Mantle cell lymphoma refractory Atypical teratoid/rhabdoid tumour of CNS – Treatment Progressive supranuclear palsy – Treatment Alport’s syndrome – Diagnostics Breast angiosarcoma – Basic Information X-linked lymphoproliferative syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BI 456906 Minzasolmin Agrostis Stolonifera Pollen Garetosmab Pegunigalsidase Alfa Erythromycin Lactobionate Letermovir LVT-001 GSK5733584 Eftilagimod Alfa Imiglucerase Other Blood Products Labetalol Hydrochloride Avacopan Antithymocyte Immunoglobulin Amikacin Mbf-118 Iloprost Trometamol Kyv-101 Gsk3915393 More therapies…

    Learn about Your Condition

    Breast cancer male Hepatic adenoma Adenovirus infection Pelvic venous thrombosis Gastrooesophageal cancer Embolism Stomatitis Squamous cell carcinoma Chordoma Polycystic liver disease Delirium Intervertebral disc protrusion Acute myocardial infarction Wolfram syndrome Prodromal Alzheimer's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Ketamine Infusion Study for Symptom Improvement in Patients with Severe Borderline Personality Disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Borderline personality disorder
    Investigated Drugs:
    • Ketamine Hydrochloride
    France

  • Study on the Safety of Mercaptamine with Standard Therapy for Hospitalized COVID-19 Pneumonia Patients Not Requiring High Oxygen Flows

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Respiratory tract infection
    • Respiratory tract infection viral
    • COVID-19
    Investigated Drugs:
    • Mercaptamine
    Italy

  • Gene Therapy Study for Familial Hemophagocytic Lymphohistiocytosis Using MUNC-CD34 and MUNC-T3 in Patients with UNC13D Gene Mutations

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Munc-Cd34
    • Munc-T3
    France

  • Study of methylprednisolone effects on recovery after major surgery in elderly patients aged 60 and over

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Methylprednisolone
    • Sodium Chloride
    Belgium

  • Study on Botulinum Toxin Type A for Treating Buerger’s Disease in Patients Eligible for Injection Therapy

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Thromboangiitis obliterans
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    France

  • Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Placebo
    Austria Germany Poland
Previous Page
1 … 904 905 906 907 908 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!